FDA Moves Cautiously to Improve Drug Safety (US News & World Report)
The Food and Drug Administration yesterday unveiled a series of initiatives intended to improve drug safety. While some changes were concrete, such as a pilot program to review the safety of drugs 18 months after they’ve been approved, many others seemed more vague, involving forming committees to develop new agency procedures. Nonetheless, FDA Commissioner Andrew von Eschenbach said the changes …